Article
Neurosciences
Per Borghammer, Jacob Horsager, Katrine Andersen, Nathalie Van den Berge, Anna Raunio, Shigeo Murayama, Laura Parkkinen, Liisa Myllykangas
Summary: The aggregation of alpha-synuclein into inclusion bodies, known as Lewy pathology, is a key feature of Parkinson's disease and Dementia with Lewy bodies. Post mortem studies have shown that Lewy pathology follows two main distribution patterns in the brain, with some patients having pathogenic alpha-synuclein originating in the enteric nervous system and others originating inside the central nervous system.
NEUROBIOLOGY OF DISEASE
(2021)
Article
Clinical Neurology
Christopher Hatton, Simona S. Ghanem, David J. Koss, Ilham Y. Abdi, Elizabeth Gibbons, Rita Guerreiro, Jose Bras, Lauren Walker, Ellen Gelpi, Wendy Heywood, Tiago F. Outeiro, Johannes Attems, Robert McFarland, Rob Forsyth, Omar M. El-Agnaf, Daniel Erskine
Summary: This study identified prion-like alpha-synuclein in the brain tissue of infants with Krabbe disease, challenging the assumption that alpha-synuclein pathology is solely age-associated and suggesting a link to biological pathways such as sphingolipid metabolism.
Article
Biochemistry & Molecular Biology
Seo-Jun Kang, Soo-Jeong Kim, Hye Rin Noh, Beom Jin Kim, Jae-Bong Kim, Uram Jin, Sun Ah Park, Sang Myun Park
Summary: In this study, the role of neuronal ApoE in the cell-to-cell transmission of alpha-synuclein (alpha-syn) was evaluated. It was found that ApoE deficiency attenuates alpha-syn uptake and release, thereby contributing to its propagation.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Review
Geriatrics & Gerontology
Nelson de Oliveira Manzanza, Lucia Sedlackova, Raj N. Kalaria
Summary: Lewy Body Disorders (LBDs) are age-related neurodegenerative diseases categorized as synucleinopathies, the second most common form of neurodegenerative dementias after Alzheimer's disease. There are currently no effective treatments for LBDs.
FRONTIERS IN AGING NEUROSCIENCE
(2021)
Article
Neurosciences
Chang-Ki Oh, Nima Dolatabadi, Piotr Cieplak, Maria T. Diaz-Meco, Jorge Moscat, John P. Nolan, Tomohiro Nakamura, Stuart A. Lipton
Summary: This article investigates the mechanism by which dysregulation of autophagic pathways leads to the accumulation of abnormal proteins and damaged organdies in neurodegenerative disorders. The authors found that pathologic protein S-nitrosylation of p62 is a critical factor for autophagic inhibition and cell-to-cell spread.
JOURNAL OF NEUROSCIENCE
(2022)
Article
Biochemistry & Molecular Biology
Shogo Moriya, Michiko Hanazono, Takeshi Fukuhara, Katsuro Iwase, Nobutaka Hattori, Masaki Takiguchi
Summary: This study investigated the involvement of macrophages/microglia in the formation and spread of alpha-synuclein (αS) fibrils. Transgenic zebrafish expressing αS in macrophages/microglia showed accumulation of αS in neurons. Transcriptome analysis revealed changes in gene expression related to kinases, ubiquitin protein ligases, neuronal activity, and transport. Furthermore, αS fibrils formed from monomers in macrophages and were spread to neurons. The ubiquitin-proteasome system modulated αS fibrils. These findings suggest that macrophages play an essential role in the formation of αS aggregates and the pathogenesis of Parkinson's disease.
CELLULAR AND MOLECULAR LIFE SCIENCES
(2022)
Article
Clinical Neurology
Ivan Martinez-Valbuena, Emily Swinkin, Enrique Santamaria, Joaquin Fernandez-Irigoyen, Valerie Sackmann, Ain Kim, Jun Li, Paulina Gonzalez-Latapi, Greg Kuhlman, Suvorit Subhas Bhowmick, Naomi P. Visanji, Anthony E. Lang, Gabor G. Kovacs
Summary: Lewy body disorders (LBD) exhibit clinical heterogeneity and differences in disease progression rates, which may be attributed to molecular diversity in alpha-synuclein (alpha-Syn). In this study, different brain regions and patients with varying clinical phenotypes were evaluated for alpha-Syn seeding capacity. Results showed that cognitive-predominant LBD patients had higher hippocampal alpha-Syn seeding, while motor-predominant patients had higher nigral alpha-Syn seeding. Additionally, patients with rapid disease progression exhibited the highest nigral seeding capacity. Proteomic analysis suggested disruption in mitochondrial function and lipid metabolism in high-seeding cases. These findings indicate the role of distinct molecular populations of alpha-Syn in phenotypic heterogeneity and disease progression in LBD.
ACTA NEUROPATHOLOGICA
(2022)
Article
Biochemistry & Molecular Biology
Emilie Tresse, Joana Marturia-Navarro, Wei Qi Guinevere Sew, Marina Cisquella-Serra, Elham Jaberi, Lluis Riera-Ponsati, Natasha Fauerby, Erling Hu, Oliver Kretz, Susana Aznar, Shohreh Issazadeh-Navikas
Summary: Damaged mtDNA plays a role in the onset and spread of sporadic Parkinson's disease with dementia, involving oxidative stress and the activation of TLR4/9 pathways.
MOLECULAR PSYCHIATRY
(2023)
Review
Clinical Neurology
David J. Koss, Susanna Campesan, Flaviano Giorgini, Tiago F. Outeiro
Summary: Intracellular vesicular trafficking is crucial for neuronal development and function, with RAB proteins playing a key role in this process; Impairment of RAB39B is associated with intellectual disability and Parkinson's disease, as well as several LBDs; Recent studies have shown altered expression of RAB39B in various LBDs.
MOVEMENT DISORDERS
(2021)
Article
Biochemistry & Molecular Biology
Issam Hmila, Nishant N. Vaikath, Nour K. Majbour, Daniel Erskine, Indulekha P. Sudhakaran, Vijay Gupta, Simona S. Ghanem, Zeyaul Islam, Mohamed M. Emara, Houari B. Abdesselem, Prasanna R. Kolatkar, Devaya K. Achappa, Tatiana Vinardell, Omar M. A. El-Agnaf
Summary: A nanobody library specific to the monomeric form of alpha-synuclein was constructed, and a nanobody Nb alpha-syn01 was identified that recognized the N-terminal region critical for alpha-synuclein aggregation. The Nb alpha-syn01 showed potential in inhibiting alpha-synuclein-seeded aggregation and reducing pathology in PD, and it was also able to recognize Lewy body pathology in human brain tissue. These findings highlight the potential of Nb alpha-syn01 as a diagnostic or therapeutic tool for PD and related disorders.
Article
Cell Biology
Jonathan D. Horvath, Maria Casas, Candice Kutchukian, Sara Creus Sanchez, Melissa R. Pergande, Stephanie M. Cologna, Sergi Simo, Rose E. Dixon, Eamonn J. Dickson
Summary: Elevated levels of a-Syn cause an increase in PM phosphoinositide PI(4,5)P2, leading to a-Syn aggregation and toxic increases in mitochondrial Ca2+ and reactive oxygen species, resulting in neuronal death. The key players in this process are PIP5K1g and ARF6. Selective inhibition of PIP5K1g or knockout of ARF6 rescues the cellular toxicity. These findings suggest that modulation of phosphoinositide metabolism could be a therapeutic target for PD and related neurodegenerative disorders.
Article
Cell Biology
Armin Bayati, Emily Banks, Chanshuai Han, Wen Luo, Wolfgang E. Reintsch, Cornelia E. Zorca, Irina Shlaifer, Esther Del Cid Pellitero, Benoit Vanderperre, Heidi M. McBride, Edward A. Fon, Thomas M. Durcan, Peter S. McPherson
Summary: This study reveals the rapid internalization and lysosomal targeting mechanism of alpha-synuclein fibrils in cells. The fibrils are internalized through a non-classical endocytic pathway and a portion of them are transferred to neighboring cells along with exosomes. These findings provide insights into the cell-to-cell propagation of alpha-synuclein fibrils.
Review
Clinical Neurology
Daniel Erskine, David Koss, Viktor I. Korolchuk, Tiago F. Outeiro, Johannes Attems, Ian McKeith
Summary: The accumulation of alpha-synuclein into insoluble intracellular deposits called Lewy bodies is the characteristic neuropathological feature of LB diseases such as Parkinson's disease. Genetic analyses and studies on model systems suggest that alpha-synuclein aggregation is a critical pathogenic event in LB diseases. Disorders not traditionally characterized as synucleinopathies may also be disproportionately vulnerable to LB formation, possibly due to disturbances in processes related to lipid homeostasis, autophagy, and mitochondrial function. These findings highlight the potential influence of impairments in these processes in the etiology of LB formation.
ACTA NEUROPATHOLOGICA
(2021)
Review
Biochemistry & Molecular Biology
Paula M. Loveland, Jenny J. Yu, Leonid Churilov, Nawaf Yassi, Rosie Watson
Summary: This study reviewed inflammation investigation methods in Lewy body dementia (LBD) and identified alterations in inflammatory signals compared to individuals without neurodegenerative disease and other neurodegenerative diseases. The results suggest that both the innate and adaptive immune system contribute to inflammation associated with LBD pathology and clinical features.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Neurosciences
Scott C. Vermilyea, Anne Christensen, Joyce Meints, Balvindar Singh, Hector Martell-Martinez, Md. Razaul Karim, Michael K. Lee
Summary: The role of tau in the development and progression of alpha-synucleinopathy was investigated in a transgenic mouse model. The results showed that loss of tau expression delayed the onset of motor deficits and the progression of alpha-synucleinopathy, improved neurodegeneration markers, and increased survival. In vitro experiments also demonstrated that tau removal prevented neurotoxicity caused by alpha-synuclein pathology. This study supports further investigation of tau as a potential therapeutic target for alpha-synucleinopathies.
TRANSLATIONAL NEURODEGENERATION
(2022)
Article
Clinical Neurology
Yuichi Riku
Article
Clinical Neurology
Akio Akagi, Yasushi Iwasaki, Akihiro Yamamoto, Hiroshi Matsuura, Toshimasa Ikeda, Maya Mimuro, Yuichi Riku, Hiroaki Miyahara, Tetsuyuki Kitamoto, Mari Yoshida
Article
Biochemistry & Molecular Biology
Yasushi Iwasaki, Keiko Mori, Masumi Ito, Yoshinari Kawai, Akio Akagi, Yuichi Riku, Hiroaki Miyahara, Atsushi Kobayashi, Tetsuyuki Kitamoto, Mari Yoshida
Summary: MM1-type sporadic Creutzfeldt-Jakob disease (sCJD) typically presents with classic symptoms and pathology, with patients usually progressing to akinetic mutism state shortly after disease onset. However, there are exceptional cases where patients can remain stable in this state for several years, despite initially exhibiting abnormal behavior in the early stages of the disease. This suggests that sCJD is a neurodegenerative disease with distinct regions of degeneration and preservation, even in cases of prolonged disease duration.
Article
Oncology
Hiroaki Miyahara, Manabu Natsumeda, Yonehiro Kanemura, Kai Yamasaki, Yuichi Riku, Akio Akagi, Wataru Oohashi, Tomoko Shofuda, Ema Yoshioka, Yuya Sato, Takashi Taga, Yuki Naruke, Ryo Ando, Daiichiro Hasegawa, Makiko Yoshida, Tsukasa Sakaida, Naoki Okada, Hiroyoshi Watanabe, Michio Ozeki, Yoshiki Arakawa, Junichi Yoshimura, Yukihiko Fujii, Souichi Suenobu, Kenji Ihara, Junichi Hara, Akiyoshi Kakita, Mari Yoshida, Yasushi Iwasaki
Summary: The study highlights the association of GLI3, NM, GFAP, and TOP2 beta expressions with prognosis in medulloblastomas, showing different clinical characteristics and outcomes among NM-/GFAP-, NM+/GFAP-, and GFAP+ subgroups.
BRAIN TUMOR PATHOLOGY
(2021)
Review
Biochemistry & Molecular Biology
Yuichi Riku, Danielle Seilhean, Charles Duyckaerts, Susana Boluda, Yohei Iguchi, Shinsuke Ishigaki, Yasushi Iwasaki, Mari Yoshida, Gen Sobue, Masahisa Katsuno
Summary: TDP-43 is a pathologic protein implicated in ALS and FTLD, with mislocalization and aggregation potentially contributing to neurotoxicity. Research focuses on examining TDP-43 pathology in autopsied patients and understanding pathways related to neuronal dysfunction in TDP-43-related diseases.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Clinical Neurology
Takashi Ando, Yuichi Riku, Akio Akagi, Hiroaki Miyahara, Mitsuaki Hirano, Toshimasa Ikeda, Hiroyuki Yabata, Ryuichi Koizumi, Chisato Oba, Saori Morozumi, Keizo Yasui, Atsuko Goto, Taiji Katayama, Satoko Sakakibara, Ikuko Aiba, Motoko Sakai, Masaaki Konagaya, Keiko Mori, Yasuhiro Ito, Hiroyuki Yuasa, Masayo Nomura, Kristine Joyce L. Porto, Jun Mitsui, Shoji Tsuji, Maya Mimuro, Yoshio Hashizume, Masahisa Katsuno, Yasushi Iwasaki, Mari Yoshida
Summary: In this study, MSA patients with prominent hippocampal involvement showed specific demographic and clinical characteristics. The severe hippocampal pathology seen in these patients suggests a potential pathological variant of MSA characterized by neuronal alpha-synucleinopathy.
Article
Clinical Neurology
Takashi Ando, Fuji Yokoi, Yuichi Riku, Akio Akagi, Hiroaki Miyahara, Masato Hasegawa, Masahisa Katsuno, Mari Yoshida, Yasushi Iwasaki
Summary: This case report describes a patient with corticobasal degeneration (CBD) who exhibited the hot cross bun (HCB) sign, which is characteristic of multiple system atrophy (MSA). Autopsy findings revealed neuropathological changes consistent with CBD in the pons, although pontocerebellar changes are unusual in CBD cases. It suggests that CBD should be considered as an underlying pathology of the HCB sign.
Article
Clinical Neurology
Yuichi Riku, Mari Yoshida, Takuya Tamura, Mikiko Kamijo, Keizo Yasui, Takashi Kameyama, Masahisa Katsuno, Gen Sobue, Yasushi Iwasaki
Summary: ALS is a motor neuron disease with clinical diagnosis challenges and diverse pathological findings. This study highlights the importance of considering nonmotor neuron symptoms in the true diagnosis of ALS, as they may indicate other underlying conditions.
Article
Clinical Neurology
Hiroyuki Yabata, Yufuko Saito, Takaaki Fukuoka, Akio Akagi, Yuichi Riku, Jun Sone, Hiroaki Miyahara, Manabu Doyu, Mari Yoshida, Yasushi Iwasaki
Summary: This article reports an autopsy case of multiple sclerosis (MS) with a long spinal cord lesion, which differs from the traditional anti-AQP4 antibody-negative neuromyelitis optica spectrum disorder (NMOSD), revealing the differences in the pathogenesis of these conditions.
Article
Clinical Neurology
Takashi Ando, Sonoko Kamoshita, Yuichi Riku, Ai Ito, Yukiyasu Ozawa, Koichi Miyamura, Masahiko Fujino, Masafumi Ito, Yoji Goto, Kazuo Mano, Akio Akagi, Hiroaki Miyahara, Masahisa Katsuno, Mari Yoshida, Yasushi Iwasaki
Summary: This report presents an autopsy case of neurolymphomatosis arising from follicular lymphoma. The patient developed progressive symptoms and eventually died despite chemotherapy. Postmortem examination revealed invasion of lymphoma cells into the nerve roots, ganglia, and subarachnoid spaces. This study highlights the manifestation of neurolymphomatosis and central nervous system invasion in low-grade follicular lymphoma.
Article
Multidisciplinary Sciences
Koyo Tsujikawa, Kohei Hamanaka, Yuichi Riku, Yuki Hattori, Norikazu Hara, Yohei Iguchi, Shinsuke Ishigaki, Atsushi Hashizume, Satoko Miyatake, Satomi Mitsuhashi, Yu Miyazaki, Mayumi Kataoka, Li Jiayi, Keizo Yasui, Satoshi Kuru, Haruki Koike, Kenta Kobayashi, Naruhiko Sahara, Norio Ozaki, Mari Yoshida, Akiyoshi Kakita, Yuko Saito, Yasushi Iwasaki, Akinori Miyashita, Takeshi Iwatsubo, Takeshi Ikeuchi, Takaki Miyata, Gen Sobue, Naomichi Matsumoto, Kentaro Sahashi, Masahisa Katsuno
Summary: This study identified the role of Filamin-A in promoting tau aggregation in progressive supranuclear palsy (PSP) patients without tau mutations. It found that nonmutated tau interacts with actin filaments through increased levels of Filamin-A, resulting in enhanced phosphorylation and insolubility of tau. The study also showed that reducing Filamin-A levels corrected aberrant tau levels in PSP cell cultures.
Article
Clinical Neurology
Mari Yoshida, Akio Akagi, Hiroaki Miyahara, Yuichi Riku, Takashi Ando, Toshimasa Ikeda, Hiroyuki Yabata, Hideyuki Moriyoshi, Ryuichi Koizumi, Yasushi Iwasaki
Summary: The neuropathological background of parkinsonism includes various neurodegenerative disorders, and macroscopic examination provides the appropriate direction for neuropathological diagnosis, while microscopic examination is based on regional distribution and fundamental proteinopathies.
Article
Clinical Neurology
Ryuichi Koizumi, Akio Akagi, Yuichi Riku, Jun Sone, Hiroaki Miyahara, Fumiaki Tanaka, Mari Yoshida, Yasushi Iwasaki
Summary: Progressive supranuclear palsy (PSP) can be diagnosed despite asymmetrical parkinsonism, and atrophy of the superior cerebellar peduncle (SCP) is more frequent in PSP than in Parkinson's disease. This study investigated the laterality of brain lesions, including SCP, in 48 PSP autopsy cases. Asymmetrical SCP atrophy was found in 14.6% of the cases, and the atrophic side of the SCP corresponded to the dominant side of tau pathology in the cerebellar dentate nucleus. This study is the first to report the presence of asymmetrical SCP atrophy and systematically asymmetrical degeneration of the Guillain-Mollaret triangle in PSP cases.
Review
Biochemistry & Molecular Biology
Yuichi Riku, Mari Yoshida, Yasushi Iwasaki, Gen Sobue, Masahisa Katsuno, Shinsuke Ishigaki
Summary: TDP-43 and tau are major pathological proteins in neurodegenerative disorders, and accumulating evidence suggests that they coexist in a subset of patients. The comorbid pathology has clinical impacts and is not a bystander in the disease process. Shared genetic risk factors and interactions between TDP-43 and tau have been reported.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Biochemistry & Molecular Biology
Hiroyuki Yabata, Yuichi Riku, Hiroaki Miyahara, Akio Akagi, Jun Sone, Makoto Urushitani, Mari Yoshida, Yasushi Iwasaki
Summary: The study aimed to evaluate the relationship between the expression level of nuclear TDP-43 and the pathological properties of cytoplasmic aggregates in ALS cases. The results showed that the maturation of cytoplasmic TDP-43 inclusions correlates with the depletion of nuclear TDP-43 in each affected neuron. This suggests that an imbalance between nuclear and cytoplasmic TDP-43 may be an essential pathway to TDP-43 pathology.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)